Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response to PTSC Request for Exclusion of Stockholder Proposal

Notwithstanding the fact that Rule 14a-8 is allowable under proposed Rule 14a-11, and unless Rule 14a-11 is retroactive, I humbly suggest that any decision can only be based on the Rules as they currently stand.

.

.

.

Be well

Share
New Message
Please login to post a reply